A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus

NCT02851849 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

148

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: LGD-6972-5 mg
DRUG: LGD-6972-10 mg
DRUG: LGD-6972-15 mg
OTHER: Placebo

Sponsor

Ligand Pharmaceuticals